EnteroBiotix vs MaaT Pharma

EnteroBiotix logo

EnteroBiotix

Mastering the microbiome, transforming lives®

55 employees · est. 2017

VS
MaaT Pharma logo

MaaT Pharma

Boosting Survival Through Innovative Immune Modulation

83 employees · est. 2014 · Lyon, France

MaaT Pharma is the older company (2017 vs 2014).

Side-by-Side Comparison

EnteroBiotix MaaT Pharma
Founded
2017 2014 older
Headquarters
Not tracked yet Lyon, France
Employees
55 83
Industry
Biotechnology, Health Care, Life Sciences Biotechnology, Health Care
Funding Stage
Venture round IPO
Total Funding
$64.00M $161.09M
Funding Rounds
5 12
Services
Not tracked yet Microbiome Ecosystem Therapies, AI-Powered Drug Development, cGMP Manufacturing, Immune Modulation for Cancer
Target Customers
Not tracked yet Cancer Patients, Healthcare Professionals, Investors, Scientific Community
Taxonomy
Microbiome TherapeuticsGut MicrobiomeDisease TreatmentInfection ControlMedical InnovationMicrobiome Research +2 Microbiome-driven TherapiesImmune ModulationOncologyGut MicrobiomeMicrobiota SymbiosisCancer Patient Survival +8
Website
enterobiotix.com maatpharma.com
EnteroBiotix logo

About EnteroBiotix

EnteroBiotix is a leading microbiome therapeutics platform company that is focused on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions to the structure and function of the gut microbiome. Founded in 2017, the company operates in the B...

MaaT Pharma logo

About MaaT Pharma

MaaT Pharma, a Lyon-based biotechnology firm established in 2014, is a trailblazer in developing innovative gut microbiome-driven therapies for immunomodulation in oncology. With the slogan "Boosting Survival Through Innovative Immune Modulation", the company is dedicated to enhancing cancer patient...

Also comparing in this category

Comparing more than these two?

Get EnteroBiotix, MaaT Pharma and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does EnteroBiotix compare?

A PDF of EnteroBiotix and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

EnteroBiotix was founded in 2017, with 55 employees. EnteroBiotix is a leading microbiome therapeutics platform company that is focused on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions. MaaT Pharma was founded in 2014, based in Lyon, France, with 83 employees. MaaT Pharma, a Lyon-based biotechnology firm established in 2014, is a trailblazer in developing innovative gut microbiome-driven therapies for immunomodulation in oncology. With the slogan "Boosting.
EnteroBiotix has raised $64.00M and MaaT Pharma $161.09M. Latest stage: EnteroBiotix Venture round, MaaT Pharma IPO.
Both work in Biotechnology and Health Care and list gut microbiome among their focus areas.

Compare EnteroBiotix with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at EnteroBiotix on 12 Sep 2024, and MaaT Pharma on 1 Dec 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes